ABHL launches first product & donates to Ministry of Health, RGoB

Azista Bhutan Healthcare Ltd. (ABHL) is FDI pharmaceutical company, a joint venture between Azista Industries Pvt. Ltd., Hyderabad, India and Druk Holding and Investments Ltd. (DHI), Bhutan with 72% and 28% shareholding, respectively. ABHL is located at Motanga Industrial Park, Samdrup Jongkhar, spread across 6.757 acres. ABHL is the first allopathic pharmaceutical manufacturer, packager, and distributor in Bhutan with the production capacity of General block 43.8 million capsules/tablets and Oncology block 16.8 million capsules/tablets per month. The Drug Regulatory Authority, RGoB, has certified ABHL for good manufacturing practice (GMP). Currently, the company has Technical Authorization to manufacture 213 goods (136 general medicines and 77 cancer drugs) across 17 distinct therapies. The oncology block is ready for production as well as packaging, while the general block is only ready for packaging. ABHL is currently working with distributors and retailers across the country, and has already received purchase orders for a few products from distributors. Oncology items will be manufactured in the coming days in response to demand from both domestic and international markets.
ABHL is donating 121,000 paracetamol 500mg (Brand:Lanol) tablets to the Ministry of Health, RGoB, which is the first product packaged at ABHL.